ECOLAB INC. reported revenue of $4.42B for the period ended 2026-06-30, +9.7% year on year. Net income was $0.53B, a 12.1% net margin on a 44.1% gross margin. The largest revenue line is Product And Equipment at 44% of the total. Free cash flow for the period was $0.49B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $4.42B | +9.7% |
| Gross profit | $1.95B | — |
| Operating income | $0.76B | — |
| Net income | $0.53B | +2.0% |
| Gross margin | 44.1% | Net margin 12.1% |
| Revenue Q/Q | +8.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| Product And Equipment | $1.93B | 43.6% |
| Product And Equipment | $1.31B | 29.7% |
| Global Pest Elimination | $0.35B | 8.0% |
| Service And Lease | $0.31B | 7.0% |
| Service And Lease | $0.30B | 6.7% |
| Global Healthcare And Life Sciences | $0.22B | 5.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $2.47B | 55.9% |
| SG&A | $1.14B | 25.9% |
| Tax & other | $0.22B | 5.1% |
| Item | Amount |
|---|---|
| Total assets | $29.93B |
| Total liabilities | $19.84B |
| Shareholders' equity | $10.08B |
| Equity / assets | 33.7% |
| Operating cash flow | $0.73B |
| Capital expenditure | $0.24B |
| Free cash flow | $0.49B |
| Cash conversion (OCF / net income) | 136% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
EIX ・ EW ・ ELV ・ EME ・ EMR ・ ETR ・ EOG ・ EQT ・ EFX ・ EQIX ・ EQR ・ ERIE
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies